Suggested targets include cytoskeletal protein degradation (Chang and Wu 2006; Song et al. 2009), neuropathy target esterase (Chang and Wu 2006; Hou et al. 2009) and calcium homeostasis (Wu and Leng 1997; Wu et al. 2007). This evidence concerns the gene DNM2 and neuropathy.